Evaluating the Role of Colposcopy for Suspicious Cervical Conditions
Official title: Role Of Colposcopy In Evaluation Of Suspicious Cervix
Run by Sohag University · NCT06673680 · Data updated 2026-11-12
This study is testing if colposcopy can help find early signs of cervical cancer in women aged 30 to 64 who have unusual cervical symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 53 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | February 28, 2025 |
| Study ends | May 30, 2025 |
| Registry record updated | November 5, 2024 |
| Trial ID | NCT06673680 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 30 to 64 with symptoms such as abnormal discharge or bleeding and clinically unhealthy cervix.
✕Probably not a fit
Patients who are pregnant, have active vaginal bleeding, or have undergone past treatments for cervical lesions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to correlate colposcopy findings with histopathological results in women with suspicious cervical lesions. It involves performing colposcopy and cervical punch biopsy to assess early detection of cervical precancer and invasive lesions. The study focuses on symptomatic women aged 30 to 64 years, evaluating various cervical abnormalities and their potential link to cervical cancer. By comparing the findings from colposcopy and biopsy, the study seeks to improve screening methods for cervical cancer.
Why it matters
Potential benefit: If successful, this study could enhance early detection and treatment of cervical cancer, potentially saving lives.
How similar studies have gone: Other studies have shown success in using colposcopy for early detection of cervical cancer, indicating this approach is well-supported.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia Exclusion Criteria: * Pregnant women * Women having active vaginal bleeding. * Any past treatment for cervical lesions. * Women having frank growth of cervix. * Women who underwent a hysterectomy.
Where it's running
-
Sohag university Hospital
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Omar K Mohamed, master
- Email: kamalo.omar@gmail.com
- Phone: +201022827251
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Building Connections: improving cancer screening, weight management, and mental health for adults in vulnerable communities
This program will try to improve cancer screening, weight management, and mental health care for adults served by community clinics in Massachusetts.
-
Shorter pelvic radiotherapy after surgery for cervical or endometrial cancer
A randomized study tests whether a shorter course of postoperative whole-pelvic radiotherapy can be as safe and effective as the standard longer schedule for women with cervical or endometrial cancer.
-
Late radiation side effects after postoperative IMRT and brachytherapy for cervical and endometrial cancer
This project will see how often and how severe late gastrointestinal and urinary side effects are in people with cervical or endometrial cancer who received postoperative IMRT and/or brachytherapy at Tata Memorial Hospital.
-
Comparing clinic-only versus clinic plus community outreach to offer HPV self-collection for cervical screening in women with HIV
This project will test whether adding community health worker outreach to clinic services helps more women living with HIV complete HPV self-collection for cervical screening.
-
Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer
This registry will see if adding local treatments such as radiation or surgery to standard systemic therapy helps people with oligo‑metastatic or oligo‑recurrent cervical cancer live longer or avoid progression.
-
Hyaluronic acid gel spacer to protect nearby organs during cervical cancer radiation
This pilot tests a hyaluronic acid gel spacer (Barrigel) to see if it helps people with cervical cancer receiving chemoradiotherapy and brachytherapy by creating space between the tumor and nearby organs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.